TABLE 1.
AD (n = 40) | NC (n = 30) | P Value | |
Age (years) | 65 ± 10 | 64 ± 8 | 0.15a |
Gender (male/female) | 18/22 | 15/15 | 0.51b |
Education years | 11.18 ± 3.19 | 12.58 ± 4.60 | 0.18a |
CDR | 0.5–2 | 0 | – |
MMSE | 8–20 (14.00 ± 6.00) | 26–30 (28.00 ± 2.00) | <0.001a |
AVLT | 8–24 (14.81 ± 4.12) | 39–52 (44.42 ± 2.74) | <0.001a |
MoCA | 8–19 (14.94 ± 3.23) | 27–30 (28.63 ± 0.67) | <0.001a |
CDT | 3–8 (6.25 ± 1.43) | 8–9 (8.71 ± 0.46) | <0.001a |
ADL | 22–45 (30 ± 9.50) | 20–22 (20 ± 0.30) | <0.001a |
HAMD | 0–3 (1.06 ± 1.08) | 0–3 (0.61 ± 1.00) | 0.07a |
HIS | 0–3 (1.16 ± 0.77) | 0–3 (1.13 ± 1.07) | 0.91a |
Data are presented as the range of minimum–maximum (mean ± SD). AD, Alzheimer’s disease; NC, normal controls; CDR, Clinical Dementia Rating; MMSE, Mini-Mental State Examination; AVLT, Auditory Verbal Learning Test; MoCA, Montreal Cognitive Assessment; CDT, Clock Drawing Task; ADL, Activity of Daily Living Scale; HAMD, Hamilton Depression Scale; HIS, Hachinski Ischemic Score; a The P value was obtained by two-sample two-tailed t-test; b The P value was obtained by two-tailed Pearson chi-square test.